Peter L. Hoang Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter L. Hoang.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter L. Hoang. Peter L. Hoang is CEO and President in TAPIMMUNE INC. ($TPIV) and Chief Executive Officer in Marker Therapeutics, Inc. ($TPIV) and President and CEO in Marker Therapeutics, Inc. ($MRKR) and Sr. VP of Bus. Development in BELLICUM PHARMACEUTICALS, INC ($BLCM).
Latest Insider Trading Transactions of Peter L. Hoang
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2021 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Buy | P | 1.75 | 142,857 | 250,000 | 332,568 | 189.7 K to 332.6 K (+75.30 %) |
| Feb 12 2021 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 3.06 | 430,000 | 1,315,800 | 430,000 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 2.12 | 388,800 | 824,256 | 388,800 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 2.12 | 41,200 | 87,344 | 41,200 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 2.12 | 388,800 | 824,256 | 388,800 | |
| Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 2.12 | 41,200 | 87,344 | 41,200 | |
| Aug 15 2019 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Buy | P | 4.62 | 10,000 | 46,200 | 189,711 | 179.7 K to 189.7 K (+5.56 %) |
| Oct 23 2018 | TPIV | Marker Therapeutic ... | Hoang Peter L. | Chief Executive Off ... | Option Exercise | A | 9.18 | 200,000 | 1,836,000 | 200,000 | |
| Oct 23 2018 | TPIV | Marker Therapeutic ... | Hoang Peter L. | Chief Executive Off ... | Option Exercise | A | 9.18 | 1,359,855 | 12,483,469 | 1,359,855 | |
| Sep 25 2017 | TPIV | TAPIMMUNE INC. | Hoang Peter L. | CEO and President | Payment of Exercise | F | 3.18 | 70,289 | 223,519 | 179,711 | 250 K to 179.7 K (-28.12 %) |
| Sep 25 2017 | TPIV | TAPIMMUNE INC. | Hoang Peter L. | CEO and President | Grant | A | 3.18 | 250,000 | 795,000 | 250,000 | 0 to 250 K |
| Jan 05 2017 | BLCM | BELLICUM PHARMACEU ... | Hoang Peter L. | Sr. VP of Bus. Deve ... | Option Exercise | A | 0.00 | 6,250 | 0 | 6,250 | |
| Jan 05 2017 | BLCM | BELLICUM PHARMACEU ... | Hoang Peter L. | Sr. VP of Bus. Deve ... | Option Exercise | A | 13.89 | 11,250 | 156,263 | 11,250 | |
| Jan 06 2016 | BLCM | BELLICUM PHARMACEU ... | Hoang Peter L. | Sr. VP of Bus. Deve ... | Option Exercise | A | 19.00 | 37,500 | 712,500 | 37,500 | |
| Feb 26 2015 | BLCM | BELLICUM PHARMACEU ... | Hoang Peter L. | Sr. VP of Bus. Deve ... | Option Exercise | A | 23.47 | 60,000 | 1,408,200 | 60,000 |
Page: 1